Summary
To study the expression of p63 and cyclooxygenase-2 (cox-2) in skin tumors and evaluate the correlation between p63 and cox-2, the expressions of cox-2 and p63 were measured by streptavidin-peroxidase complex immunohistochemical technique in 17 cases of skin squamous cell carcinoma (SCC), 19 cases of Bowen’s disease(Bowen), 11 cases of actinic keratosis(AK), 12 cases of seborreic keratosis(SK) and 13 specimens of normal skin. Our results showed that the expression of p63 in skin squamous cell carcinoma, Bowen’s disease and actinic keratosis were significantly higher than that in seborreic keratosis, while the expression of p63 in seborreic keratosis was significantly higher than that in normal skin. The expression of cox-2 in skin squamous cell carcinoma, Bowen’s disease and actinic keratosis were significantly higher than that in seborreic keratosis, while no statistical difference was noted in the expression of cox-2 between seborreic keratosis and normal skin. Cox-2 expression was positively correlated with the high p63 expression in malignant skin tumors. The increased expression of cox-2 and p63 may play an important role in the development of skin tumors and work synergetically in malignant skin tumors.
Similar content being viewed by others
References
Schmale H, Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene, 1997,15:1363–1367
Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci, 2000,30(1):3–21
Yang A, Kaghad M, Wang Y et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell, 1998,2(3):305–316
Parsa R, Yang A, Mckeon F et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol, 1999, 113(6):1099–1105
Miller C, Zhang M, He Y et al. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP21 and CRE nuclear blinding proteins. J Cell Biochem, 1998,69(4):392–413
Bakhle Y S. COX-2 and cancer: a new approach to an old problem. Br J Pharmacol, 2001,134(6):1137–1150
Higashi Y, Kanekura T, Kanzki T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer, 2000,86(5):667–671
Dohn M, Zhang S, Chen X. p63 alpha and Delta Np63 alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene, 2001, 20(25):3193–3205
Kawabe A, Shimada Y, Uchida S et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol, 2002,80(2):79–88
Zahner G, Wolf G, Ayoub M et al. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1. J Biol Chem, 2002,277(12):9763–9771
Author information
Authors and Affiliations
Corresponding author
Additional information
WU Yan, female, born in 1975, Doctor in Charge
Rights and permissions
About this article
Cite this article
Wu, Y., Liu, H. & Li, J. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors. J. Huazhong Univ. Sc. Technol. 27, 206–208 (2007). https://doi.org/10.1007/s11596-007-0227-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0227-6